Searched for
GLOBAL ANTI OBESITY MARKET
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 croreHDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder...- Buy the dip, stay invested: Matt Orton sees more upside for global marketsGlobal markets are gaining traction as geopolitical worries ease and AI companies report strong earnings. Matt Orton of Raymond James highl...
- Global Market Today: Asian stocks jump with US futures on Micron outlookAsian markets surged, mirroring US futures, as Micron Technology's stellar sales forecast reignited AI trade confidence. The chipmaker's sh...
- Global Market: How SK Hynix's AI bet helped it eclipse Samsung in market valueSK Hynix’s rise to South Korea’s most valuable listed company reflects a long-term bet on HBM chips that became central to the AI boom. Bac...
- Global Markets: MSCI keeps South Korea in emerging-market index, cites market accessibility hurdlesSouth Korea remains in the emerging-market category as MSCI cites persistent foreign exchange market accessibility issues. Despite ongoing ...
- K-Drama on Tech Street: AI rout hits global marketsTechnology stocks experienced a significant downturn, pulling major indices lower as a sharp selloff in Korean chipmakers raised concerns a...
- Global Market | European shares slip on Fed hike bets, tech dragEuropean markets opened lower Tuesday, impacted by anticipated US Federal Reserve rate hikes and concerns over escalating corporate AI inve...
- Oil Price Today (June 22): Crude oil rises above $80 as Iran shuts Strait of Hormuz again. What are experts saying?Brent crude futures rose 54 cents, or 0.67%, to $81.11 a barrel, after briefly touching $82.30 at the start of trading. U.S. West Texas Int...
- India imposes anti-dumping duty on chemical imported from China, EU, USIndia has slapped a five-year anti-dumping duty on a key chemical used in rubber and tyre manufacturing, imported from China, the EU, and t...
- Ceasefire, Inflation, Elections: 5 themes driving global markets this week
- Tech, crypto firms to help tackle illegal wildlife tradeAnnouncement made as part of a business forum convened by Prince William and The Royal Foundation's United for Wildlife during London Cli...
- Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
Load More
